| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 1, 2026 | Sell(S) | 38K | $17.00 | $643K | 9.2M |
| Jun 30, 2026 | Sell(S) | 25K | $17.13 | $429K | 9.2M |
| Jun 29, 2026 | Sell(S) | 274K | $17.23 | $4.7M | 9.2M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001877589-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Theravance Biopharma, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001877589-26-000001"
Use Arkolith to summarize insider buying and selling at Theravance Biopharma, Inc. over the last 90 days and cite the filings.